—In a global study of 614 adults with chronic hepatitis B (CHB), treatment compliance was affected by obstacles such as physical functioning and healthcare service accessibility, making clear the need ...
Douglas T. Dieterich, MD, Director, Institute for Liver Medicine and Professor of Medicine at Icahn School of Medicine in New York City, focuses on the emerging use of hepatitis B surface antigen, ...
Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of ...
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...
NEWTON, Mass., October 15, 2025--(BUSINESS WIRE)--ClearB Therapeutics, Inc., a clinical-stage biotechnology company committed to developing therapies to drive functional cure in patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results